epidermal Growth Factor Receptor (egfr) Mutation in Exon 19 (p.e749q) Confers Resistance to Gefitinib in One Patient With Lung Adenocarcinoma

Giovenzio Genestreti, Dario de Biase, Monica Di Battista, Giovanna Cavallo, Roberta Degli Esposti, Michela Visani, Giorgia Acquaviva, Thomas Brand, Annalisa Pession, Giovanni Tallini, Alba A. Brandes

doi:10.1016/j.cllc.2017.01.003

DOI: 10.1016/j.cllc.2017.01.003

,

PMID: 28162944

Issn Print: 1525-7304

Publication Date: 2017/05/01

Print

Giovenzio Genestreti; Dario de Biase; Monica Di Battista; Giovanna Cavallo; Roberta Degli Esposti; Michela Visani; Giorgia Acquaviva; Thomas Brand; Annalisa Pession; Giovanni Tallini; Alba A. Brandes

+ Author Information

Author Information: Department of Medical Oncology, Bellaria Hospital, AUSL Bologna-IRCCS Institute of Neurological Sciences, Bologna, Italy


		Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


		Loading Related Articles

Epidermal Growth Factor Receptor (EGFR) Mutation in Exon 19 (p.E749Q) Confers Resistance to Gefitinib in One Patient With Lung Adenocarcinoma

Abstract

Related Topics